Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

489-513 (Activation loop from InterPro)

Target domain

347-624 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for O80939

Entry ID Method Resolution Chain Position Source
AF-O80939-F1 Predicted AlphaFoldDB

47 variants for O80939

Variant ID(s) Position Change Description Diseaes Association Provenance
ENSVATH01961645 7 T>P No 1000Genomes
ENSVATH05673146 10 F>L No 1000Genomes
ENSVATH05673145 16 L>I No 1000Genomes
ENSVATH01961644 17 I>L No 1000Genomes
tmp_2_15816884_G_C 26 N>K No 1000Genomes
tmp_2_15816862_T_C 34 N>D No 1000Genomes
tmp_2_15816852_G_A 37 T>M No 1000Genomes
tmp_2_15816844_A_G 40 S>P No 1000Genomes
ENSVATH01961641 46 T>N No 1000Genomes
ENSVATH00263742 49 P>A No 1000Genomes
ENSVATH00263740 99 I>S No 1000Genomes
ENSVATH13563622 123 Y>F No 1000Genomes
ENSVATH01961639 129 L>F No 1000Genomes
ENSVATH01961639 129 L>I No 1000Genomes
ENSVATH01961638 130 A>T No 1000Genomes
ENSVATH05673143 132 N>D No 1000Genomes
ENSVATH05673142 134 N>K No 1000Genomes
ENSVATH05673141 136 T>A No 1000Genomes
tmp_2_15816538_C_A 142 V>F No 1000Genomes
ENSVATH00263736 148 L>V No 1000Genomes
ENSVATH01961637 168 K>N No 1000Genomes
ENSVATH13563621 168 K>T No 1000Genomes
ENSVATH00263735 179 D>N No 1000Genomes
tmp_2_15816417_C_G 182 G>A No 1000Genomes
tmp_2_15816408_T_C 185 K>R No 1000Genomes
tmp_2_15816387_C_A 192 R>L No 1000Genomes
ENSVATH01961636 227 A>T No 1000Genomes
ENSVATH01961635 228 V>I No 1000Genomes
ENSVATH13563620 267 A>T No 1000Genomes
tmp_2_15816141_C_T 274 R>K No 1000Genomes
ENSVATH01961634 299 L>Q No 1000Genomes
ENSVATH01961633 301 L>F No 1000Genomes
ENSVATH01961632 302 I>F No 1000Genomes
ENSVATH01961631 306 I>F No 1000Genomes
ENSVATH01961631 306 I>V No 1000Genomes
ENSVATH13563618 381 E>A No 1000Genomes
tmp_2_15815778_C_G 395 S>T No 1000Genomes
tmp_2_15815685_T_A 426 N>I No 1000Genomes
ENSVATH00263723 482 G>R No 1000Genomes
tmp_2_15815491_A_C 491 F>V No 1000Genomes
tmp_2_15815316_T_A 549 E>V No 1000Genomes
ENSVATH00263718 552 Q>H No 1000Genomes
tmp_2_15815298_T_G 555 D>A No 1000Genomes
tmp_2_15815137_G_A 609 P>S No 1000Genomes
tmp_2_15815127_C_A 612 R>I No 1000Genomes
ENSVATH01961610 641 V>A No 1000Genomes
ENSVATH13563617 662 G>S No 1000Genomes

4 associated diseases with O80939

[MIM: 204000]: Leber congenital amaurosis 1 (LCA1)

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:12365911, ECO:0000269|PubMed:15123990, ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:27475985, ECO:0000269|PubMed:30319355, ECO:0000269|PubMed:8944027, ECO:0000269|PubMed:9888789}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 601777]: Cone-rod dystrophy 6 (CORD6)

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors. {ECO:0000269|PubMed:12552567, ECO:0000269|PubMed:15111605, ECO:0000269|PubMed:18332321, ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:20517349, ECO:0000269|PubMed:21552474, ECO:0000269|PubMed:22194653, ECO:0000269|PubMed:23734073, ECO:0000269|PubMed:24480840, ECO:0000269|PubMed:25515582, ECO:0000269|PubMed:27475985, ECO:0000269|PubMed:30319355, ECO:0000269|PubMed:9618177, ECO:0000269|PubMed:9683616}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 215500]: Choroidal dystrophy, central areolar, 1 (CACD1)

A form of central areolar choroidal dystrophy, a retinal disease that affects the macula and results in a well-demarcated circumscribed area of atrophy of the pigment epithelium and choriocapillaris. CACD1 inheritance is autosomal recessive. {ECO:0000269|PubMed:22695961}. Note=The disease may be caused by variants affecting the gene represented in this entry.

[MIM: 618555]: Night blindness, congenital stationary, 1I (CSNB1I)

A form of congenital stationary night blindness, a non-progressive retinal disorder characterized by impaired night vision or in dim light, with good vision only on bright days. CSNB1I patients present with night blindness from infancy or early childhood. Visual acuity is preserved, but some patients have color vision and/or visual field defects. Progression to mild retinitis pigmentosa may occur. CSNB1I inheritance is autosomal recessive. {ECO:0000269|PubMed:29559409}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:12365911, ECO:0000269|PubMed:15123990, ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:27475985, ECO:0000269|PubMed:30319355, ECO:0000269|PubMed:8944027, ECO:0000269|PubMed:9888789}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors. {ECO:0000269|PubMed:12552567, ECO:0000269|PubMed:15111605, ECO:0000269|PubMed:18332321, ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:20517349, ECO:0000269|PubMed:21552474, ECO:0000269|PubMed:22194653, ECO:0000269|PubMed:23734073, ECO:0000269|PubMed:24480840, ECO:0000269|PubMed:25515582, ECO:0000269|PubMed:27475985, ECO:0000269|PubMed:30319355, ECO:0000269|PubMed:9618177, ECO:0000269|PubMed:9683616}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • A form of central areolar choroidal dystrophy, a retinal disease that affects the macula and results in a well-demarcated circumscribed area of atrophy of the pigment epithelium and choriocapillaris. CACD1 inheritance is autosomal recessive. {ECO:0000269|PubMed:22695961}. Note=The disease may be caused by variants affecting the gene represented in this entry.
  • A form of congenital stationary night blindness, a non-progressive retinal disorder characterized by impaired night vision or in dim light, with good vision only on bright days. CSNB1I patients present with night blindness from infancy or early childhood. Visual acuity is preserved, but some patients have color vision and/or visual field defects. Progression to mild retinitis pigmentosa may occur. CSNB1I inheritance is autosomal recessive. {ECO:0000269|PubMed:29559409}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for O80939

Type Name Position InterPro Accession
domain Cyclin, N-terminal 36 - 143 IPR006671
domain Cyclin-like domain 41 - 139 IPR013763-1
domain Cyclin-like domain 152 - 231 IPR013763-2

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Membrane ; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
carbohydrate binding Binding to a carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
transmembrane receptor protein serine/threonine kinase activity Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

4 GO annotations of biological process

Name Definition
defense response to bacterium Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
defense response to oomycetes Reactions triggered in response to the presence of oomycetes that act to protect the cell or organism.
protein phosphorylation The process of introducing a phosphate group on to a protein.
response to salicylic acid Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salicylic acid stimulus.

15 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P46197 NPR2 Atrial natriuretic peptide receptor 2 Bos taurus (Bovine) PR
Q06806 Tie1 Tyrosine-protein kinase receptor Tie-1 Mus musculus (Mouse) SS
Q02858 Tek Angiopoietin-1 receptor Mus musculus (Mouse) SS
P18910 Npr1 Atrial natriuretic peptide receptor 1 Rattus norvegicus (Rat) PR
P51842 Gucy2f Retinal guanylyl cyclase 2 Rattus norvegicus (Rat) PR
P16067 Npr2 Atrial natriuretic peptide receptor 2 Rattus norvegicus (Rat) PR
O81291 LECRK44 L-type lectin-domain containing receptor kinase IV.4 Arabidopsis thaliana (Mouse-ear cress) PR
O81292 LECRK43 L-type lectin-domain containing receptor kinase IV.3 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M1G4 LECRK15 Probable L-type lectin-domain containing receptor kinase I.5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M345 LECRK42 L-type lectin-domain containing receptor kinase IV.2 Arabidopsis thaliana (Mouse-ear cress) PR
Q9STF0 LECRKS3 Receptor like protein kinase S.3 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M2S4 LECRKS4 L-type lectin-domain containing receptor kinase S.4 Arabidopsis thaliana (Mouse-ear cress) PR
Q96285 LECRK55 L-type lectin-domain containing receptor kinase V.5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FG33 LECRKS5 Probable L-type lectin-domain containing receptor kinase S.5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LSR8 LECRK19 L-type lectin-domain containing receptor kinase I.9 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MFLKLLTIFF FFFFNLIFQS SSQSLNFAYN NGFNPPTDLS IQGITTVTPN GLLKLTNTTV
70 80 90 100 110 120
QKTGHAFYTK PIRFKDSPNG TVSSFSTSFV FAIHSQIAIL SGHGIAFVVA PNASLPYGNP
130 140 150 160 170 180
SQYIGLFNLA NNGNETNHVF AVELDTILST EFNDTNDNHV GIDINSLKSV QSSPAGYWDE
190 200 210 220 230 240
KGQFKNLTLI SRKPMQVWVD YDGRTNKIDV TMAPFNEDKP TRPLVTAVRD LSSVLLQDMY
250 260 270 280 290 300
VGFSSATGSV LSEHYILGWS FGLNEKAPPL ALSRLPKLPR FEPKRISEFY KIGMPLISLF
310 320 330 340 350 360
LIFSFIFLVC YIVRRRRKFA EELEEWEKEF GKNRFRFKDL YYATKGFKEK GLLGTGGFGS
370 380 390 400 410 420
VYKGVMPGTK LEIAVKRVSH ESRQGMKEFV AEIVSIGRMS HRNLVPLLGY CRRRGELLLV
430 440 450 460 470 480
YDYMPNGSLD KYLYNTPEVT LNWKQRIKVI LGVASGLFYL HEEWEQVVIH RDVKASNVLL
490 500 510 520 530 540
DGELNGRLGD FGLARLYDHG SDPQTTHVVG TLGYLAPEHT RTGRATMATD VFAFGAFLLE
550 560 570 580 590 600
VACGRRPIEF QQETDETFLL VDWVFGLWNK GDILAAKDPN MGSECDEKEV EMVLKLGLLC
610 620 630 640 650 660
SHSDPRARPS MRQVLHYLRG DAKLPELSPL DLSGSGMMFG VHDGFSELGM SYSSSVFKGF
670
TGGSSIADSQ LSGGR